NCT01446237View on ClinicalTrials.gov

U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne

NACompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

June 1, 2011

Primary Completion Date

December 1, 2011

Study Completion Date

December 15, 2011

Conditions
Acne Vulgaris
Interventions
OTHER

acne system - benzoyl peroxide 2.5%, Salicyclic Acid 0.5%

over the counter acne system

Trial Locations (9)

11790

GSK Investigational Site, Stony Brook

20850

GSK Investigational Site, Rockville

27262

GSK Investigational Site, High Point

37922

GSK Investigational Site, Knoxville

40217

GSK Investigational Site, Louisville

78759

GSK Investigational Site, Austin

94538

GSK Investigational Site, Fremont

07109

GSK Investigational Site, Belleville

07042

GSK Investigational Site, Montclair

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Stiefel, a GSK Company

INDUSTRY

NCT01446237 - U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne | Biotech Hunter | Biotech Hunter